Brain wave alert: new tool could predict delirium hours before it strikes after heart surgery

NCT ID NCT07686900

First seen Jul 07, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

After heart surgery, up to half of patients may experience a sudden state of confusion called delirium, which can slow recovery. This study aims to build a computer-based early warning system that combines real-time brain wave (EEG), brain oxygen, and heart function measurements to predict delirium 1 to 6 hours before it starts. Researchers will enroll 200 adults aged 18 to 80 in the ICU after heart surgery, continuously recording their vital signals and regularly checking their mental state. The goal is to give doctors a window to intervene early, potentially improving recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this early warning system could help doctors prevent delirium after heart surgery, leading to faster recovery and shorter ICU stays.
What could go wrong
This is an observational study to develop a prediction tool, not a treatment test. The system may not prove accurate enough for real-world use, and it does not test any intervention to prevent delirium.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC SURGICAL PROCEDURES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Emergence Delirium

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Zhongda hospital Southeast University

    Nanjing, Jiangsu, China

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.